Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03636581
Other study ID # BHS-1333
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date August 8, 2018
Est. completion date April 25, 2021

Study information

Verified date January 2022
Source New York Institute of Technology
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study will be a randomized cross-over design over the course of 2 academic years. 40 subjects -20 overweight women and 20 over weight men will be recruited. Each subject will have body composition tested, blood lipid profile, and resting metabolic rate done in the beginning of the first academic year and at the end of the first academic year. The intervention group will receive activity trackers, diet counseling, and fitness counseling for one academic year. The second year, all outcome measures (a body scan, blood lipid profile, and resting metabolic rate) will be performed again at the start of the academic year 2, except the intervention group will now be the control group and the control group will now receive the same intervention. All final outcome measures will be performed at the end of the second year.


Recruitment information / eligibility

Status Completed
Enrollment 40
Est. completion date April 25, 2021
Est. primary completion date April 25, 2021
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 35 Years
Eligibility Inclusion Criteria: - Male and female NYITCOM students between the ages of 18-35 - BMI = 25.0 - Body fat % >19% for males; >33% for women (will be determined by body composition scan) - Own their own smartphone Exclusion Criteria: - People who have used weight loss smartphone applications in the past 6 month - People who have used an activity tracker in past 6 months - Anyone who answers yes to one or more questions on the PAR-Q screen - Any contraindication to having a duel x-ray body scan performed based on the American College of Radiology's practice guidelines

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Lifestyle counseling
This group will receive online education modules to educate them on exercise prescription, nutrition and behavioral changes.

Locations

Country Name City State
United States New York Institute of Technology Old Westbury New York

Sponsors (1)

Lead Sponsor Collaborator
New York Institute of Technology

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Body fat percentage Body composition 4 months
Secondary Step Count Activity based on step count 4 months
Secondary Resting Metabolic Rate Resting metabolic rate changes as per oxygen consumption 4 months
Secondary Total Cholesterol fasting serum mg/dL 4 months
Secondary High Density Lipoproteins fasting serum mg/dL 4 months
Secondary Low Density Lipoproteins fasting serum mg/dL 4 months
Secondary Triglycerides fasting serum mg/dL 4 months
Secondary Hemoglobin A1C fasting plasma % of total hemoglobin 4 months
See also
  Status Clinical Trial Phase
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Terminated NCT03299881 - Safety and Effectiveness of Transcutaneous Electrical Nerve Stimulation (TENS)-Assisted Weight Loss N/A
Completed NCT02805478 - Fat-Associated Cardiovascular Organ Dysfunction
Active, not recruiting NCT02558920 - Meta-analyses of Food Sources of Fructose-Containing Sugars and Obesity
Completed NCT03759743 - Evaluate the Efficacy and Safety of LMT1-48 on Reducing Body Fat in Overweight Subject N/A
Completed NCT03610958 - Safety and Performance Evaluation of the Epitomee Device for Enhancing Satiety and Weight Loss. N/A
Completed NCT03678766 - CHARGE: Controlling Hunger and ReGulating Eating N/A
Completed NCT04430465 - Effects of Wholegrains on Children's Health (KORN) N/A
Completed NCT04117802 - Effects of Maple Syrup on Gut Microbiota Diversity and Metabolic Syndrome N/A
Completed NCT05376865 - Effects of Vitamin D Supplementation on Obesity, Inflammatory and Metabolic Markers N/A
Completed NCT03625427 - Effect of Palmitoleic Acid on C-reactive Protein N/A
Active, not recruiting NCT03435445 - Online Platform for Healthy Weight Loss (POEmaS) N/A
Enrolling by invitation NCT05576116 - Combined Bariatric Surgery and Pancreas After Kidney Transplantation for Type II Diabetics N/A
Recruiting NCT05249465 - Spark: Finding the Optimal Tracking Strategy for Weight Loss in a Digital Health Intervention N/A
Active, not recruiting NCT06023095 - A Study of LY3502970 in Chinese Participants With Obesity or Are Overweight With Weight-related Comorbidities Phase 1
Completed NCT03648892 - Brain Dopamine Function in Human Obesity Early Phase 1
Recruiting NCT02887950 - Resistant Starch, Epigallocatechin Gallate and Chlorogenic Acid for Body Weight Loss in Menopause N/A
Terminated NCT02796144 - MEtformin and Lorcaserin for WeighT Loss in Schizophrenia Phase 4
Terminated NCT02743598 - Liraglutide for HIV-associated Neurocognitive Disorder Phase 4
Completed NCT03097237 - High Fiber Rye Foods for Weight and Body Fat Reduction N/A